The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 140.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 20.00 (14.286%)
Open: 150.00
High: 150.00
Low: 150.00
Prev. Close: 150.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Universe Group hires CFO as new CEO also joins

Fri, 23rd Apr 2021 15:43

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

----------

Universe Group PLC - Southampton, Hampshire-based retail management, payment and loyalty systems - Hires Adrian Wilding as chief financial officer and Graham Bird as non-executive director. Wilding replaces Carmel Warren, who was serving as interim CFO. Wilding was chief executive officer and CFO of payments firm CR7 Services Ltd. Previously, he worked at former FTSE 250 listing Just Retirement Group PLC. Bird is CFO of AIM-listed escape room operator Escape Hunt PLC. Universe Group recently hired Neil Radley as its new chief executive officer. Radley had led Jaja Finance Ltd, a fintech lending firm. He replaces Jeremy Lewis, who departs on April 30.

----------

Ashmore Group PLC - emerging markets-focused asset manager - Hires Helen Beck as non-executive director from June 1, while Anne Pringle will retire from the board on June 30. Beck is retiring as a partner at accountants Deloitte LLP on May 31. Deloitte is a remuneration advisor to Ashmore.

----------

Faron Pharmaceuticals Oy - Turku, Finland-based biopharmaceuticals - Appoints Anne Whitaker as non-executive director following the passing of resolutions at Faron's annual general meeting on Friday. Whitaker is chair of Aerami Therapeutics Holdings Inc, a private life science company, having previously been chief executive officer. Prior to Aerami, Whitaker was CEO of Novoclem Therapeutics Inc.

----------

Chaarat Gold Holdings Ltd - gold miner in Armenia and mine developer in Kyrgyz Republic - Hires Sandy Stash as independent non-executive director, starting May 1. Stash is a non-executive director of FTSE 250-constituent Diversified Gas & Oil PLC.

----------

Dalata Hotel Group PLC - Dublin-based hotel operator in Ireland and UK - Alf Smiddy to retire as non-executive director at April 29 AGM, as part of company's plan to refresh board.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
18 Mar 2021 16:06

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
12 Feb 2021 10:40

Faron Pharmaceuticals Raises EUR15 Million In Share Placing

Faron Pharmaceuticals Raises EUR15 Million In Share Placing

Read more
11 Feb 2021 17:49

IN BRIEF: Faron Pharmaceuticals Plans To Raise EUR15 Million

IN BRIEF: Faron Pharmaceuticals Plans To Raise EUR15 Million

Read more
26 Jan 2021 11:45

IN BRIEF: Faron Pharmaceuticals Gets US Approval For Covid-19 Trial

IN BRIEF: Faron Pharmaceuticals Gets US Approval For Covid-19 Trial

Read more
20 Jan 2021 15:12

Faron Notes "Remarkable" Observations From Bexmarilimab Trial

Faron Notes "Remarkable" Observations From Bexmarilimab Trial

Read more
20 Jan 2021 10:40

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

LONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal

Read more
18 Jan 2021 10:41

LONDON AIM WINNERS & LOSERS: CPPGroup Earnings To Beat Forecasts

LONDON AIM WINNERS & LOSERS: CPPGroup Earnings To Beat Forecasts

Read more
18 Jan 2021 10:22

Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment

Faron Pharmaceuticals Gets USD6 Million Funding For Covid-19 Treatment

Read more
23 Nov 2020 21:12

IN BRIEF: Four Cohorts In Faron Pharmaceuticals Study Move To Part 3

IN BRIEF: Four Cohorts In Faron Pharmaceuticals Study Move To Part 3

Read more
24 Sep 2020 14:02

IN BRIEF: Faron Pharmaceuticals Says Virus Barely Affected Operations

IN BRIEF: Faron Pharmaceuticals Says Virus Barely Affected Operations

Read more
17 Sep 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
18 Aug 2020 11:55

Faron Gets EUR2.5 Million Loan Guarantee For Traumakine Production

Faron Gets EUR2.5 Million Loan Guarantee For Traumakine Production

Read more
15 Jun 2020 13:05

IN BRIEF: Faron Pharma Receives EUR2.1 Million Loan To Develop Product

IN BRIEF: Faron Pharma Receives EUR2.1 Million Loan To Develop Product

Read more
15 Jun 2020 12:44

Faron Pharmaceuticals gets Finnish state loan for manufacturing process

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced plans to initiate a new "state-of-the-art" process for the manufacturing of 'interferon' (IFN) beta-1a on Monday.

Read more
11 Jun 2020 13:51

Faron receives EIC grant for 'MATINS' study

(Sharecast News) - Clinical-stage biopharmaceuticals company Faron Pharmaceuticals has been selected to receive a €2.5m (£2.24m) grant from the European Innovation Council's 'Accelerator' pilot scheme, it announced on Thursday, to progress the 'MATINS' study, and related business activities.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.